Mechanisms of NF-κB p65 and strategies for therapeutic manipulation.

作者: Sivagami Giridharan , Mythily Srinivasan

DOI: 10.2147/JIR.S140188

关键词:

摘要: The transcription factor NF-κB is a critical regulator of immune and inflammatory responses. In mammals, the NF-κB/Rel family comprises five members: p50, p52, p65 (Rel-A), c-Rel, Rel-B proteins, which form homo- or heterodimers remain as an inactive complex with inhibitory molecules called IκB proteins in resting cells. Two distinct signaling pathways have been described: 1) canonical pathway primarily activated by pathogens mediators, 2) noncanonical mostly developmental cues. most abundant pathologic stimuli via p65:p50 heterodimer. Disproportionate increase subsequent transactivation effector integral to pathogenesis many chronic diseases such rheumatoid arthritis, bowel disease, multiple sclerosis, even neurodegenerative pathologies. Hence, has pivotal point for intense drug discovery development. This review begins overview p65-mediated followed discussion strategies that directly target context inflammation.

参考文章(128)
De Stefano D, Oligonucleotides decoy to NF-kappaB: becoming a reality? Discovery Medicine. ,vol. 12, pp. 97- 105 ,(2011)
C Riccardi, [GILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoids]. Annali di igiene : medicina preventiva e di comunità. ,vol. 22, pp. 53- 59 ,(2010)
Y Sawa, R Morishita, Ken Suzuki, K Kagisaki, Y Kaneda, Kazuhiro Maeda, K Kadoba, Hikaru Matsuda, None, A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury. Circulation. ,vol. 96, ,(1997)
Nora Sundahl, Jolien Bridelance, Claude Libert, Karolien De Bosscher, Ilse M. Beck, Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds. Pharmacology & Therapeutics. ,vol. 152, pp. 28- 41 ,(2015) , 10.1016/J.PHARMTHERA.2015.05.001
Takanori Kanazawa, Tomohiro Hamasaki, Takahiro Endo, Kuniko Tamano, Kana Sogabe, Yasuo Seta, Tadaaki Ohgi, Hiroaki Okada, Functional peptide nanocarriers for delivery of novel anti-RelA RNA interference agents as a topical treatment of atopic dermatitis. International Journal of Pharmaceutics. ,vol. 489, pp. 261- 267 ,(2015) , 10.1016/J.IJPHARM.2015.05.003
David E. Uehling, Philip A. Harris, Recent progress on MAP kinase pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. ,vol. 25, pp. 4047- 4056 ,(2015) , 10.1016/J.BMCL.2015.07.093
Sheri M. Fujihara, Jeffrey S. Cleaveland, Laura S. Grosmaire, Karen K. Berry, Karen A. Kennedy, James J. Blake, James Loy, Bruce M. Rankin, Jeffrey A. Ledbetter, Steven G. Nadler, A d-Amino Acid Peptide Inhibitor of NF-κB Nuclear Localization Is Efficacious in Models of Inflammatory Disease The Journal of Immunology. ,vol. 165, pp. 1004- 1012 ,(2000) , 10.4049/JIMMUNOL.165.2.1004
Jinming Yang, Guo-Huang Fan, Brian E. Wadzinski, Hiroaki Sakurai, Ann Richmond, Protein Phosphatase 2A Interacts with and Directly Dephosphorylates RelA Journal of Biological Chemistry. ,vol. 276, pp. 47828- 47833 ,(2001) , 10.1074/JBC.M106103200
Lin-Feng Chen, Warner C. Greene, Shaping the nuclear action of NF-κB Nature Reviews Molecular Cell Biology. ,vol. 5, pp. 392- 401 ,(2004) , 10.1038/NRM1368